US Dollar vs Yen

登録して、同じ考えを持つ投資家と議論するためのアクティブなフォーラムで相互作用するためのアクティブなフォーラムに参加してください。

ホーム
投資
株式
イギリス
LSE
Leclanch (0QP6) 銘柄情報

Leclanch (0QP6)

1.98

0.00

(0.00%)

終了 6月21日 12:30AM

Leclanch (0QP6) 銘柄情報

ポートフォリオを強化: リアルタイムのディスカッションと実用的な取引アイデア。

プレミアム

通貨

1.98

( - )

買値

1.98

売値

1.98

出来高

0.00

0.00 日の範囲 0.00

1.98 52 週間の範囲 1.98

時価総額

前日終値

1.98

始値

-

時刻

最終取引時間

財務取引量

-

VWAP

-

平均取引量 (3 か月)

CHF 102,882

発行済株式数

1,600,732,020

配当利回り

PER

-0.9

1 株当たり利益 (EPS)

-0.09

歳入

19.44M

純利益

-79.18M

Leclanché SA, together with its subsidiaries, designs, develops, and manufactures customized turnkey energy storage solutions for electricity generation and transmission, mass transportation, heavy industrial machines, and special low voltage battery systems. It operates through three segments: Stat... Leclanché SA, together with its subsidiaries, designs, develops, and manufactures customized turnkey energy storage solutions for electricity generation and transmission, mass transportation, heavy industrial machines, and special low voltage battery systems. It operates through three segments: Stationary Business Unit, E-Mobility Business Unit, and Specialty Battery Business Unit. The Stationary Business Unit segment sells customized systems to support customers in electricity generation markets, such as renewable energy integration, micro-grid, or distributed power; and in transmission and distribution markets. The E-Mobility Business Unit segment sells customized systems to support customers in the mass marine, and road and rail transportation. The Specialty Battery Business Unit segment develops and delivers turn-key customized solutions and off-the-shelf solutions incorporating battery storage and/or charging solutions use in-house and third-party technologies for civil, military, medical, and industrial machineries markets. The company operates in Switzerland, the Netherlands, Canada, Norway, Italy, France, the United States, Slovakia, Denmark, Croatia, Spain, Germany, and internationally. Leclanché SA was incorporated in 1909 and is headquartered in Yverdon-les-Bains, Switzerland. 詳細を表示

セクター

-

業界

-

ウェブサイト

www.leclanche.com

本社

Yverdon-les-bains, Switzerland

設立

2026

Leclanch is listed in the sector of the ロンドン証券取引所 with ticker 0QP6. The last closing price for Leclanch was CHF1.98. Over the last year, Leclanch shares have traded in a share price range of CHF 1.98 to CHF 1.98.

Leclanch currently has 1,600,732,020 shares in issue. The market capitalisation of Leclanch is CHF3.17 billion. Leclanch has a price to earnings ratio (PE ratio) of -0.90.

Leclanché selected to provide 10 MWh advanced battery system for Scandlines' "PR24" zero-emission freight ferry

Leclanché selected to provide 10 MWh advanced battery system for Scandlines' "PR24" zero-emission...

期間 †	前日比	前日比 %	始値	高値	安値	平均出来高	VWAP
1	0	0	0	0	0	0	0	DE
4	0	0	0	0	0	0	0	DE
12	0	0	0	0	0	0	0	DE
26	0	0	1.98	1.98	1.98	2925	1.98	DE
52	0	0	1.98	1.98	1.98	2726	1.98	DE
156	0	0	1.98	1.98	1.98	3612	1.98	DE
260	0	0	1.98	1.98	1.98	2771	1.98	DE

0QP6 - Frequently Asked Questions (FAQ)

What is the current Leclanch share price?

The current share price of Leclanch is CHF 1.98

How many Leclanch shares are in issue?

Leclanch has 1,600,732,020 shares in issue

What is the market cap of Leclanch?

The market capitalisation of Leclanch is CHF 3.17B

What is the 1 year trading range for Leclanch share price?

Leclanch has traded in the range of CHF 1.98 to CHF 1.98 during the past year

What is the PE ratio of Leclanch?

The price to earnings ratio of Leclanch is -0.9

What is the cash to sales ratio of Leclanch?

The cash to sales ratio of Leclanch is 6.95

What is the registered address of Leclanch?

The registered address for Leclanch is Avenue des DEcouvertes 14C, Yverdon-les-Bains, Vaud, 1400

What is the Leclanch website address?

The website address for Leclanch is www.leclanche.com

R1250gs

R1250gs 2分前

My target is to own 1000 Sol's and put them into a self-custody crypto wallet for a long term investment. I think Sol has a tremendous potential to grow big...

Mister4

Mister4 8分前

Yes, the NWS was certainly illegal. That being said, in my opinion, the terms of the conservatorship are a major Takings violation. Who gives a loan that when paid off the lender owns 95% of the collateral for the loan? The warrants alone represent 80% of the outstanding stock. Who besides the gover

CanItBThisEZ2Make

CanItBThisEZ2Make 11分前

BEST SELLERS RANK (BSR) IS 356 45 Estimated Sold on Amazon Since APRIL 1 - 2ND Quarter 2026
https://investorshub.advfn.com/uimage/uploads/2024/4/24/cnxttVOS_5G_GIF.gif
https://www.amazon.com/Vos-RDGL5GX55-B-01-VOS-5G-Dongle/dp/B0C66KHZLP

NOTE: In theory, when BSR Value D

SeaBlue

SeaBlue 17分前

Rules for thee and not for me - that is what is going on with the Trumper family AND CONgress.

I'll watch the Tom Lee video in a while - gotta head out on some errands.

I am looking forward to what is hopefully good news from the federal/provincial govt. by the end of

CaptBeer

CaptBeer 17分前

REDUCE-IT CKM: In REDUCE-IT secondary prevention patients, the CKM syndrome was associated with incremental CVD risk compared with MetS without diabetes and normal renal function. IPE treatment further reduced CVD risk in patients with CKM, thereby supporting a role for this therapy in affected pati

toohot

toohot 19分前

Conductor TOOHOT checking in—thanks for your patience during the brief pause.
The BIEL Train Bound for Glory resumes boarding this Monday.
Entry prices remain low—for now.
All aboard to those joining the ride. 🚂
$BIEL

BUY $BI

Implanting

Implanting 19分前

Here's the interview. Frank G. is one of my favorites.

https://www.youtube.com/watch?v=bNuljOP4Ric

Investor2014

Investor2014 20分前

Don't forget the 58 amazing scientists signing away their reputation on the peer reviewed paper and the entire Scientific Advisory Board that must have been implicit too.

The alternative is simply a poorly run biotech with a drug that may not work well enough to gain approval and a bu

DJknows

DJknows 24分前

Of course I agree with you ... there's no way IQM Quantum is not familiar with Perkinamine and who knows to what extent they're using it.

Dr. Ciesla is joing an apparently impressive team at IQM, which has four co-founders according to its website:

https://iqm.tech/pres

learningcurve2020

learningcurve2020 26分前

“Safe” yet no pediatric trials for the most vulnerable? Safe is good but can also be a red flag that the drug/cell therapy is not active enough. My guess is skip right over DCVAX to genetically modified DC’s. 🤷‍♀️. Hopefully the CDMO is preparing??

Sunnybank

Sunnybank 27分前

Mates-Have a wonderful Father's Day with parents and/or children. Fair Winds to All!

Monksdream

Monksdream 27分前

GOOG!, buy the dip
https://investorshub.advfn.com/uimage/uploads/2026/6/21/pyifrIMG_2248.png

Monksdream

Monksdream 27分前

GOOG!, buy the dip
https://investorshub.advfn.com/uimage/uploads/2026/6/21/pyifrIMG_2248.png

SeaBlue

SeaBlue 29分前

Video with Frank G. Just watch from about 37:20 to 39:10. This is good news, particularly for Duparquet, but also for Springpole. Improved permitting times will help FF a lot. I am also glad because the money generated will be good for Canada.
https://www.youtube.com/watch?v=bNuljOP4Ri

learningcurve2020

learningcurve2020 31分前

T cell and Genetically modified dendritic cells.

Lacey1

Lacey1 31分前

What did it cost to produce that report? And how long to write it up. Looks like a pure hit piece. Effective in driving the price to all time lows. Where do we go from here. We need a partner. We need to submit to the FDA for NDA this year. Is that still a possibility? With Kennedy at the

ScottishTexan

ScottishTexan 34分前

I have a very different take. They know that 400m shares is enough to pay themselves and seems like good news. They know that the market is disappointed that it’s not sandbox. The 20000-1 split was brutal but at least we are able to salvage something from it . The market makers have to be much more

Soog

Well ok; I'll go along with this if you feel it's good. It must have been planned all the time.

GetSeriousOK

GetSeriousOK 37分前

I don't know what happened, and it certainly looks like Mayer is no longer CEO, but I think you're lying when you say that "Zubcevik stated Mayer is no longer with the company."

Did you just have coffee with her? LOL

I don't think Mayer left the company. I don't know wh

Implanting

Implanting 40分前

Trump would have to make it look like whatever problems Stategy/Saylor have are related to them and NOT to Bitcoin, so that's the trick. Trump wants to pick it up cheap, but not make it look like Bitcoin has no value or is a worthless ponzi, so it would have to be a Strategy related issue, not a Bit

eliminate

eliminate 41分前

Apparently
the FBI has captured the 2 top fraudsters on their list but so far haven’t captured Madoff or Ivan Bolskys buddies on any of the exchanges Guess we will have to see who else is playing in the pool beside the monument

straightword

straightword 42分前

Easy cop out. You say this because you know with certainty that you will NEVER be able to meet it!! So much for those s-called patents worth "billions and billons ongoing" huh? The fact is that they aren't!!

Genz2

I think Steven Sprague or Bill Solms who worked for Microsoft should call them up and say “Look guys and gals, Wave could do so much to bring Microsoft to new heights and dominate cybersecurity with BETTER SECURITY!!!” With the Trusted Computing Group behind them, and with Wave’s and Microsoft’s ma

rosemountbomber

rosemountbomber 44分前

Thanks for posting. Remarkable stuff.

mdb1

The 20,000 millionaire employee at SpaceX love the "baa" and are thankful for the sheep followers. Only in America .. go Elon.

Xtrackers Harvest CSI300...

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

ADVFN

すでにアカウントをお持ちですか？サインイン

アカウントをお持ちでないですか？登録

登録することで、ADVFN の利用規約を読み、理解し、同意したこと、および私が個人投資家であることを確認します。